1. Home
  2. AKBA vs NL Comparison

AKBA vs NL Comparison

Compare AKBA & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.22

Market Cap

251.0M

Sector

Health Care

ML Signal

HOLD

Logo NL Industries Inc.

NL

NL Industries Inc.

HOLD

Current Price

$5.77

Market Cap

283.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
NL
Founded
2007
1891
Country
United States
United States
Employees
N/A
2263
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
251.0M
283.1M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
AKBA
NL
Price
$1.22
$5.77
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.67
N/A
AVG Volume (30 Days)
4.1M
41.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
10.22%
EPS Growth
93.94
N/A
EPS
N/A
0.09
Revenue
N/A
$158,285,000.00
Revenue This Year
N/A
$9.32
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$64.33
Revenue Growth
N/A
8.46
52 Week Low
$0.82
$5.04
52 Week High
$3.81
$8.60

Technical Indicators

Market Signals
Indicator
AKBA
NL
Relative Strength Index (RSI) 46.66 44.47
Support Level $1.16 $5.71
Resistance Level $1.52 $5.87
Average True Range (ATR) 0.07 0.18
MACD -0.02 -0.02
Stochastic Oscillator 7.59 33.03

Price Performance

Historical Comparison
AKBA
NL

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About NL NL Industries Inc.

NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: